Sridhar V. Basavaraju

Sridhar V. Basavaraju

Auto-generated profile, based on publicly available information

Sridhar V. Basavaraju

Division of Healthcare Quality Promotion Centers for Disease Control and Prevention Atlanta Georgia USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2023 in Transfusion
Verified
Journal Article
Closed access
RFRebecca J. Free
Rebecca J. Free
MSMathew R. P. Sapiano
Mathew R. P. Sapiano
JOJoel L. Chavez Ortiz
Joel L. Chavez Ortiz
PSPhylicia Stewart
Phylicia Stewart
JBJames Berger
James Berger
SBSridhar V. Basavaraju
Sridhar V. Basavaraju

1 September 2014 in Emerging Infectious Diseases
Verified
Journal Article
Open access
SBSridhar V. Basavaraju
Sridhar V. Basavaraju
MKMatthew J. Kuehnert
Matthew J. Kuehnert
SZSherif R. Zaki
Sherif R. Zaki
JSJames J. Sejvar
James J. Sejvar
The cause of encephalitis among solid organ transplant recipients may be multifactorial; the disease can result from infectious or noninfectious etiologies. During 2002–2013, the US Centers for Disease Control and Prevention investigated several encephalitis clusters among transplant recipients. Cases were caused by infections from transplant-transmitted pathogens: West Nile virus, rabies virus, lymphocytic choriomeningitis virus, and Balamuthia mandrillaris amebae. In many of the clusters, identification of the cause was complicated by delayed diagnosis due to the rarity of the disease, geographic distance separating transplant recipients, and lack of prompt recognition and reporting systems. Establishment of surveillance systems to detect illness among organ recipients, including communication among transplant center physicians, organ procurement organizations, and public health authorities, may enable the rapid discovery and investigation of infectious encephalitis clusters. These transplant-transmitted pathogen clusters highlight the need for greater awareness among clinicians, pathologists, and public health workers, of emerging infectious agents causing encephalitis among organ recipients.

1 August 2021 in Transfusion
Verified
Journal Article
Open access
PDF file
SMSanjida J. Mowla
Sanjida J. Mowla
MSMathew R. P. Sapiano
Mathew R. P. Sapiano
JJJefferson M. Jones
Jefferson M. Jones
JBJames J. Berger
James J. Berger
SBSridhar V. Basavaraju
Sridhar V. Basavaraju
Introduction: Supplemental data from the 2019 National Blood Collection and Utilization Survey (NBCUS) are presented and include findings on donor characteristics, autologous and directed donations and transfusions, platelets (PLTs), plasma and granulocyte transfusions, pediatric transfusions, transfusion‐associated adverse events, cost of blood units, hospital policies and practices, and implementation of blood safety measures, including pathogen reduction technology (PRT).Methods: National estimates were produced using weighting and imputation methods for a number of donors, donations, donor deferrals, autologous and directed donations and transfusions, PLT and plasma collections and transfusions, a number of crossmatch procedures, a number of units irradiated and leukoreduced, pediatric transfusions, and transfusion‐associated adverse events.Results: Between 2017 and 2019, there was a slight decrease in successful donations by 1.1%. Donations by persons aged 16–18 decreased by 10.1% while donations among donors >65 years increased by 10.5%. From 2017 to 2019, the median price paid for blood components by hospitals for leukoreduced red blood cell units, leukoreduced apheresis PLT units, and for fresh frozen plasma units continued to decrease. The rate of life‐threatening transfusion‐related adverse reactions continued to decrease. Most whole blood/red blood cell units (97%) and PLT units (97%) were leukoreduced.Conclusion: Blood donations decreased between 2017 and 2019. Donations from younger donors continued to decline while donations among older donors have steadily increased. Prices paid for blood products by hospitals decreased. Implementation of PRT among blood centers and hospitals is slowly expanding.

11 March 2025 in Transfusion
Verified
Journal Article
Closed access
KMKelsey McDavid
Kelsey McDavid
RLRebecca Lien
Rebecca Lien
JOJoel Chavez Ortiz
Joel Chavez Ortiz
TBTatiana Bradley
Tatiana Bradley
ALAngelina Luciano
Angelina Luciano
IKIan Kracalik
Ian Kracalik

1 November 2021 in Emerging Infectious Diseases
Verified
Journal Article
Open access
PDF file
SMSanjida J. Mowla
Sanjida J. Mowla
NDNaomi A. Drexler
Naomi A. Drexler
CCCara C. Cherry
Cara C. Cherry
PAPallavi D. Annambholta
Pallavi D. Annambholta
IKIan T. Kracalik
Ian T. Kracalik
SBSridhar V. Basavaraju
Sridhar V. Basavaraju
Physicians should be aware that these infections are rare but can have severe outcomes.

19 May 2010 in Vox Sanguinis
Verified
Journal Article
Closed access
PDF file
SBS. V. Basavaraju
S. V. Basavaraju
JMJ. Mwangi
J. Mwangi
JNJ. Nyamongo
J. Nyamongo
CZC. Zeh
C. Zeh
DKD. Kimani
D. Kimani
LML. H. Marum
L. H. Marum